Nutrient quality
TRAACS chromium nicotinate glycinate is a well-characterized chelate with strong absorption potential. The form and dose are well matched, while the focused design keeps use straightforward.
Analysis
One serving provides 200 mcg of chromium as TRAACS chromium nicotinate glycinate chelate. The amount fits common focused supplementation without being unusually high.
The branded chelate provides excellent form identity and absorption confidence. Chromium may support normal insulin action when intake or status is inadequate, but expected effects on body weight are modest and depend heavily on diet and activity.
The package provides 180 listed servings with exceptional practical value. The focused design makes dose and purpose easy to assess, though it offers no broader metabolic ingredients.
Pros
Uses TRAACS chromium nicotinate glycinate chelate Provides a clearly stated 200 mcg amount Offers 180 listed servings Avoids unrelated active ingredients
Cons
Supports only one metabolic pathway Does not directly increase metabolic rate Weight-management effects are likely modest Full excipient details are not supplied
Warnings
The 200 mcg chromium amount may add to the effects of insulin or other glucose-lowering medicines and increase low-blood-sugar risk. Chromium can reduce levothyroxine absorption when taken together; follow pharmacist or label guidance for separating the doses. People with significant kidney or liver disease should confirm regular chromium use with a clinician.
